102 related articles for article (PubMed ID: 22402432)
1. What Is the best treatment for HIV-associated multicentric Castleman disease?
Bower M; Dalla Pria A
Clin Adv Hematol Oncol; 2012 Mar; 10(3):207-9. PubMed ID: 22402432
[No Abstract] [Full Text] [Related]
2. Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.
Peker D; Martinez AE; Schwartz MA; Cusnir M
Clin Adv Hematol Oncol; 2012 Mar; 10(3):204-6. PubMed ID: 22402431
[No Abstract] [Full Text] [Related]
3. [Castleman's disease, HIV and rituximab].
Valencia ME; López V; Corcuera MT; Del Val D
Rev Clin Esp; 2012 Feb; 212(2):118-9. PubMed ID: 21924712
[No Abstract] [Full Text] [Related]
4. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease.
Neuville S; Agbalika F; Rabian C; Brière J; Molina JM
Am J Hematol; 2005 Aug; 79(4):337-9. PubMed ID: 16044438
[TBL] [Abstract][Full Text] [Related]
5. Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.
Stary G; Kohrgruber N; Herneth AM; Gaiger A; Stingl G; Rieger A
AIDS; 2008 Jun; 22(10):1232-4. PubMed ID: 18525273
[No Abstract] [Full Text] [Related]
6. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease.
Casquero A; Barroso A; Fernández Guerrero ML; Górgolas M
Ann Hematol; 2006 Mar; 85(3):185-7. PubMed ID: 16341862
[TBL] [Abstract][Full Text] [Related]
7. Mixed variant multicentric Castleman disease treated with rituximab: case report.
Mian H; Leber B
J Pediatr Hematol Oncol; 2010 Nov; 32(8):622. PubMed ID: 20921905
[No Abstract] [Full Text] [Related]
8. Autoimmune hemolytic anemia with warm-reactive immunoglobulin M antibody in multicentric Castleman disease.
Tajima K; Yamamoto H; Suzuki I; Kato Y; Hatano K; Takahashi S; Sato M; Kato T
Ann Hematol; 2013 Jun; 92(6):849-51. PubMed ID: 23180435
[No Abstract] [Full Text] [Related]
9. Parsonage-Turner syndrome during the treatment of HIV/HHV8-related multicentric Castleman disease.
Patier de la Peña JL; González-García A; Prieto Pareja E; Norman FF; Rojas Marcos J; Benito Paniagua D
Rev Clin Esp (Barc); 2014 Mar; 214(2):e15-7. PubMed ID: 24365755
[No Abstract] [Full Text] [Related]
10. The first reported case and management of multicentric Castleman's disease associated with Kaposi's sarcoma in an HIV-2-infected patient.
Bouvresse S; Marcelin AG; Franck N; Regnier S; Damond F; Tulliez M; Dupin N
AIDS; 2007 Jul; 21(11):1492-4. PubMed ID: 17589201
[No Abstract] [Full Text] [Related]
11. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody.
Gholam D; Vantelon JM; Al-Jijakli A; Bourhis JH
Ann Hematol; 2003 Dec; 82(12):766-8. PubMed ID: 12898190
[TBL] [Abstract][Full Text] [Related]
12. Multicentric Castleman disease complicated by tumor lysis syndrome after systemic chemotherapy.
Lee JH; Kwon KA; Lee S; Oh SY; Kwon HC; Han JY; Hong SH; Kim SH
Leuk Res; 2010 Jan; 34(1):e42-5. PubMed ID: 19747731
[No Abstract] [Full Text] [Related]
13. Multicentric Castleman's disease & HIV infection.
Cotter A; Lambert J; O'Gorman P
Ir Med J; 2009 Oct; 102(9):294-5. PubMed ID: 19902650
[TBL] [Abstract][Full Text] [Related]
14. Siltuximab (Sylvant) for treatment of multicentric castleman's disease.
Med Lett Drugs Ther; 2015 Jan; 57(1459):e8. PubMed ID: 25555075
[No Abstract] [Full Text] [Related]
15. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena.
Ocio EM; Sanchez-Guijo FM; Diez-Campelo M; Castilla C; Blanco OJ; Caballero D; San Miguel JF
Am J Hematol; 2005 Apr; 78(4):302-5. PubMed ID: 15795923
[TBL] [Abstract][Full Text] [Related]
16. Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease.
van Aalderen MC; Brinkman K; van den Berk GE; Terpstra WE
Neth J Med; 2010 Feb; 68(2):87-90. PubMed ID: 20167961
[TBL] [Abstract][Full Text] [Related]
17. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
[TBL] [Abstract][Full Text] [Related]
18. IL-1RA agonist (anakinra) in the treatment of multifocal castleman disease: case report.
Galeotti C; Tran TA; Franchi-Abella S; Fabre M; Pariente D; Koné-Paut I
J Pediatr Hematol Oncol; 2008 Dec; 30(12):920-4. PubMed ID: 19131781
[TBL] [Abstract][Full Text] [Related]
19. Multicentric Castleman disease presenting with fever.
Smith C; Lee-Miller C; Dishop MK; Cost C; Wang M; Asturias EJ
J Pediatr; 2014 Dec; 165(6):1261-5. PubMed ID: 25282064
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune pancreatitis in the setting of Castleman disease.
Maithel SK; Pratt W; Kelleher T; Avigan D; Goldman H; Pfeifer W; Pihan GA; Vollmer CM
Pancreas; 2007 Nov; 35(4):384-7. PubMed ID: 18090252
[No Abstract] [Full Text] [Related]
[Next] [New Search]
